An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Treatment Acquiring Popularity Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to message these profiles directly for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Worries
However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.
Several professionals said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Service Response and Material Removal
According to the social media company, the service has taken down problematic content and prohibited related hashtags and search suggestions. The company stated it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.
Online Trading Operations
Research also found communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, positive reviews and step-by-step guides for preparing or injecting at residence.
After moments of joining one group, a seller shared contact information, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage.
Item Information and Pricing
Inside these groups, messages show black plastic packages with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service said it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.
Her team has previously seen patients injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially serious health risks”.
